Compare State Street SPDR S&P Biotech ETF (XBI) vs XP Inc. Class A Common Stock (XP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
State Street SPDR S&P Biotech ETF vs XP Inc. Class A Common Stock — how do they compare? State Street SPDR S&P Biotech ETF trades at $154.06 (market cap $10.11B), while XP Inc. Class A Common Stock trades at $32.04 (market cap $15.33B). The key difference: XP Inc. Class A Common Stock is the larger of the two by market cap, and XP Inc. Class A Common Stock pays a 0.66% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold State Street SPDR S&P Biotech ETF for 37 Days and XP Inc. Class A Common Stock for 0 Days on average.
| XBI | XP | |
|---|---|---|
Market Cap | $10.11B | $15.33B |
Volume | 12,903,266 | 14,214,379 |
Sector | Broad Market / Factor | Financials |
52-Week High | $169.55 | $30.21 |
52-Week Low | $104.99 | $14.94 |
Typical Hold Time | 37 Days | 0 Days |
Enterprise Value | — | $24.96B |
Dividend Yield | — | 0.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
XBI trades at $153.34, up 2.07% today, but faces bearish technical signals with 17 sell indicators versus 4 buys. The ETF's modified equal-weight structure provides exposure to over 150 biotech companies, benefiting from recent M&A activity and positive clinical trial catalysts. Current price sits near resistance at $154, with support at $147.
Biotech sector optimism is growing with cancer vaccine breakthroughs and improved capital access, though XBI's 0.35% expense ratio is higher than broader healthcare ETFs. Key risks include sector volatility and regulatory uncertainty, while analyst consensus remains neutral with 100% hold rating.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →About XP Inc. Class A Common Stock
XP Inc. provides investment products and financial services in Brazil. Its platform includes brokerage, investment funds, fixed-income products, banking, insurance, and retirement solutions.
Read more on XP →
